Washington State Department of Health
(DOH)

The winnowing of bills through the first cutoff on Wednesday was underway, and some legislation had been greatly revised to continue forward momentum.

Testimony on a Senate bill on cannabis concentrates was similar to the House counterpart, but some new points were made after the sponsor raised the specter of Reefer Madness.

A new bill to raise the age limit on cannabis concentrates and require additional educational resources received support from prevention groups but opposition from cannabis stakeholders.

With some calls for additional data or formatting changes, testimony in a hearing on legislation to set up a WSLCB data dashboard was largely supportive.

Legislation to alter a planned transfer of cannabis lab accreditation authority was broadly praised by the sponsor, agency leaders, and cannabis sector stakeholders. 

Leadership went over the first legislative briefing of 2024, including active bills and possible amendments, then heard about social equity applicants, education, staffing, and tribal updates.

Lawmakers reintroduced 2023 legislation, nudging one cannabis bill forward, and planned to introduce expansive new hemp processor legislation before hearing three cannabis-related bills.

A rules update acknowledged more delays in some projects before public comments showed a divide on the fairness of social equity licensing and questioned cannabis research topics.

DOH staff heard stories and suggestions from patients, advocates, and other stakeholders on how to improve affordability, access, and understanding of medically compliant cannabis products.

Lab representatives and other stakeholders pointed out discrepancies, redundancies, and costs related to proposed lab quality standards leading staff to ultimately choose to rework the rules.